Monkey B Virus (Herpesvirus simiae): Transmission, Symptoms, and Prevention

Monkey B virus (Macacine herpesvirus 1, formerly Cercopithecine herpesvirus 1) is an alphaherpesvirus endemic in macaques (rhesus, cynomolgus, pig-tailed). It causes mild or asymptomatic infection in natural hosts but is highly lethal in humans (≈80% fatality without treatment).

Transmission

  • Direct Contact: Bites, scratches, needlesticks with contaminated sharps.
  • Mucosal Exposure: Splash to eyes, nose, mouth with saliva, CSF, urine, or neural tissue.
  • Fomites: Contaminated cages, equipment (virus survives hours on surfaces).
  • At-Risk Groups: Lab workers, veterinarians, animal care staff, researchers handling macaques or their tissues.

Clinical Course in Humans

  • Incubation: 2 days – 5 weeks (usually 5–21 days).
  • Prodrome: Flu-like: fever, chills, myalgia, headache, fatigue.
  • Neurologic Progression: Paresthesias at exposure site → ascending paralysis, encephalitis (confusion, seizures, cranial nerve palsies), respiratory failure, coma.
  • Mortality: 70–80% untreated; survivors often have severe neurological sequelae.

Diagnosis & Treatment

  • Diagnosis: PCR of CSF, blood, vesicle fluid; serology (paired sera).
  • PEP (Post-Exposure Prophylaxis): **Start immediately** after exposure – valacyclovir 1g PO TID or acyclovir 800mg PO 5×/day for 14 days. IV acyclovir if neurologic symptoms.
  • Supportive: ICU care, mechanical ventilation, seizure control.

Prevention

  • Biosafety Level 2/3 practices for macaque work.
  • PPE: Double gloves, face shield, gown, bite-resistant sleeves.
  • Engineering controls: Restraint devices, needleless systems.
  • Immediate wound cleansing: 15-min scrub with povidone-iodine or chlorhexidine.
  • Report all exposures instantly; baseline and follow-up serology.

No vaccine exists. Rigorous occupational health programs are essential for at-risk personnel.

Viral Infections - Related Articles